CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VEZYSM. The owner is based in CHANGSHA CITY,HUNAN PROVINCE.

NO. 1A,1ST FLOOR,BUILDING 1,DIGITAL MEDICAL DEVICE PARK,NO. 1029,GAOJIAPO ROAD

CHANGSHA LONGPING INDUSTRIAL DEVELOPMENT ZONE,FURONG DISTRICT

CHANGSHA CITY,HUNAN PROVINCE , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VEZYSM
VEZYSM
Registered 2024

Trademark Classifications

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. have?

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. file in?

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CHANGSHA BOTE BIOTECHNOLOGY CO., LTD.'s most well-known trademarks?

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as VEZYSM. These are among 1 currently registered trademark in the portfolio.

What is CHANGSHA BOTE BIOTECHNOLOGY CO., LTD.'s trademark registration success rate?

CHANGSHA BOTE BIOTECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.